CTI BioPharma Ratios and Metrics

Market cap in millions UGX. Fiscal year is January - December.

Millions UGX. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Aug '25 Aug 7, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	600,000	333,750	225,000	212,500	238,750	300,000	Upgrade
Market Cap Growth	48.33%	48.33%	5.88%	-11.00%	-20.42%	-4.00%	Upgrade
Last Close Price	40.00	20.02	12.15	9.99	8.74	10.07	Upgrade
PE Ratio	4.48	2.49	1.93	1.74	2.65	3.60	Upgrade
PS Ratio	2.71	1.51	1.12	1.10	1.51	2.17	Upgrade
PB Ratio	0.74	0.41	0.32	0.35	0.43	0.66	Upgrade
P/FCF Ratio	-	-	-	-	-	3.76	Upgrade
P/OCF Ratio	-	-	-	-	-	3.71	Upgrade
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.07	Upgrade
Debt / FCF Ratio	-	-	-	-	-	0.40	Upgrade
Return on Equity (ROE)	17.67%	17.67%	17.64%	20.98%	17.91%	19.66%	Upgrade
Return on Assets (ROA)	4.55%	4.55%	4.44%	5.28%	4.20%	4.18%	Upgrade
Earnings Yield	22.33%	40.14%	51.72%	57.50%	37.72%	27.77%	Upgrade
FCF Yield	-22.64%	-40.69%	-133.16%	-69.69%	-66.51%	26.62%	Upgrade
Dividend Yield	10.00%	19.98%	16.46%	20.01%	19.06%	16.55%	Upgrade
Payout Ratio	22.40%	22.40%	25.78%	40.92%	27.65%	-	Upgrade
Buyback Yield / Dilution	-	-	-	-	-4.86%	-6.44%	Upgrade
Total Shareholder Return	10.00%	19.98%	16.46%	20.01%	14.21%	10.12%	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.